Innovative Medicine Focus Daiichi Sankyo's strong emphasis on developing high-impact, life-changing therapies for cancer and cardiovascular diseases presents opportunities to collaborate or supply advanced biopharmaceutical components, research tools, and innovative drug delivery systems.

Strategic Partnerships Recent collaborations like the partnership with General Proximity and joint development of antibody-drug conjugates indicate an openness to strategic alliances, making them a potential target for providers offering biotech collaborations, licensing, or joint research initiatives.

Growth in ADC Portfolio Given their active development of multiple antibody-drug conjugates and licensing agreements, there is a demand for specialized manufacturing, clinical trial services, and innovative pharmaceutical technologies tailored to ADC production and testing.

Regulatory and Clinical Expansion Daiichi Sankyo’s focus on advancing regulatory processes and presenting new clinical research at international conferences suggests a need for regulatory consulting, clinical data management, and health technology assessment services to support their product launches and clinical trials.

Global Market Engagement As a company with an international presence, Daiichi Sankyo presents opportunities for cross-border sales in research tools, medical devices, and healthcare solutions that enable expansion into global markets, particularly in Asia and North America.